BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6223586)

  • 1. [Experimental study on immunochemotherapy using schizophyllan].
    Mitani M; Iwano K; Arika T; Kikuchi M
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):122-8. PubMed ID: 6223586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer--a randomized comparative study by an envelope method].
    Nakao I; Uchino H; Orita K; Kaido I; Kimura T; Goto Y; Kondo T; Takino T; Taguchi T; Nakajima T; Fujimoto S; Miyazaki T; Miyoshi A; Yachi A; Yoshida K; Ogawa N; Furue H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1146-59. PubMed ID: 6223584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of SPG (schizophyllan) as a therapeutic adjuvant after surgery of gastric cancer--controlled study by an envelope method].
    Fujimoto S; Orita K; Kimura T; Kondo T; Taguchi T; Yoshida K; Ogawa N; Furue H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1135-45. PubMed ID: 6223583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination therapy of radiation and SPG (schizophyllan) in the treatment of MM46 tumor transplanted in C3H/He mice].
    Ogawa Y; Maeda T; Hirota S; Yoshida S; Ohara S; Morita M; Hamada F; Inomata T; Morita S; Sawada A
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):87-95. PubMed ID: 2939159
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer (the second report)--a randomized controlled study].
    Furue H; Uchino H; Orita K; Kimura T; Goto Y; Kondo T; Sato S; Takino T; Taguchi T; Nakao I
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1272-7. PubMed ID: 3159346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of pions and SPG (Sonifilan, Schizophyllan), a biological response modifier for mouse tumor systems.
    Ogawa Y; Goodman GB; Chaplin DJ; Grulkey W; Lam GK
    Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1415-20. PubMed ID: 2142485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination therapy of radiation and schizophyllan (SPG) in C3H mouse squamous-cell carcinoma NR-S1].
    Arika T; Amemiya K; Mochizuki S
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2841-7. PubMed ID: 2944485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan.
    Yamamoto T; Yamashita T; Tsubura E
    Invasion Metastasis; 1981; 1(1):71-84. PubMed ID: 6234252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of radiation and Sizofiran (SPG) on the tumor growth and metastasis on squamous-cell carcinoma NR-S1 in syngeneic C3H/He mice.
    Arika T; Amemiya K; Nomoto K
    Biotherapy; 1992; 4(2):165-70. PubMed ID: 1622736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral administration of sizofiran activates Langerhans cell and T-cell infiltration in cervical cancer.
    Nakano T; Oka K; Hanba K; Morita S
    Clin Immunol Immunopathol; 1996 Apr; 79(1):79-86. PubMed ID: 8612354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reaction induced by X-rays and pions and its stimulation by schizophyllan (SPG).
    Inomata T; Goodman GB; Fryer CJ; Chaplin DJ; Palcic B; Lam GK; Nishioka A; Ogawa Y
    Br J Cancer Suppl; 1996 Jul; 27():S122-5. PubMed ID: 8763863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor activity of schizophyllan (SPG) against syngeneic ACI/N rat tumor, AMC-60 fibrosarcoma and BC-47 bladder cancer].
    Mitani M; Arika T; Matsuo T; Asano T
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1809-17. PubMed ID: 6236752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
    Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K
    J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.
    Sugawara I; Lee KC; Wong M
    Cancer Immunol Immunother; 1984; 16(3):137-44. PubMed ID: 6322974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-related immunomodulating activities of an anti-tumor glucan, sizofiran (SPG).
    Tsuchiya Y; Igarashi M; Inoue M; Kumagai K
    J Pharmacobiodyn; 1989 Oct; 12(10):616-25. PubMed ID: 2534316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of anti-tumor effect of interleukin 2 with sizofiran in mice.
    Ikeuchi K
    Keio J Med; 1991 Sep; 40(3):132-8. PubMed ID: 1753556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacies of schizophyllan (SPG) on advanced gastric cancer].
    Fujimoto S
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1447-50. PubMed ID: 2531270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunochemotherapy with tegafur and schizophyllan for stomach cancer--report of 2 cases].
    Yokota S; Yoshida J; Fuse Y; Nishida K; Abe T; Takino T
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2062-8. PubMed ID: 6225394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case report of patient with advanced stomach carcinoma of linitis plastica type responding to multi-immunotherapy and chemotherapy].
    Yagita A; Orima I; Okada N; Ootsuka S; Oda T; Takeuchi N; Hosaka N; Matsumoto H; Itoh H; Ono M
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):196-9. PubMed ID: 3026254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.